Arquivos Brasileiros de Endocrinologia & Metabologia
versão On-line ISSN 1677-9487
CARDIA, Maria Silvia et al. Comparação entre diferentes métodos para avaliar a presença de auto-anticorpos dirigidos ao receptor de TSH em pacientes com moléstia de Graves-Basedow. Arq Bras Endocrinol Metab [online]. 2001, vol.45, n.6, pp.563-569. ISSN 1677-9487. http://dx.doi.org/10.1590/S0004-27302001000600010.
Antibodies directed to the TSH receptor (TSHRAbs), detected by TRAb as TSH-binding inhibitory immunoglobulin, and cyclic AMP production by CHO cells expressing human TSH recombinant receptor (CHO-rhTSHR) were determined in 52 patients (36F/16M) with Graves' disease (DGB), both before and at 6 and 12 months of continuous treatment with metimazol (40-60mg/day) associated with L-thyroxine (100mg/day). Another group of 20 patients (12F/8M) was referred for radioiodine (RAI) treatment. The TSHRAbs were detected by radioreceptor assay in none of the 80 normal control individuals and in 47/52 patients (90.4%) with a mean±SEM value of 56.7±3.9%. There was a significant decrease of mean TRAb values at 6 and 12 months of MMI + LT4 therapy. Six months after RAI, TRAb decreased significantly to 30.7±4.5%. In contrast, TSHRAbs were determined by bioassay in none of the 80 normal control subjects but in all 52 patients with a mean±SEM of 1122±409%. Similarly to TRAb there was a non-significant decrease at 6 and 12 months of MMI + LT4 therapy. Thus, the sensitivity of TSHRAbs detected by bioassay in 52 patients with active DGB seems to be greater than that detected by radioreceptor. In conclusion, the radioreceptor assay values as well as the bioassay for TSHRAbs may be useful for the diagnosis of active DGB.
Palavras-chave : Graves-Basedow disease; TRAb; AntiTPO; CHO cells; Cyclic AMP; TSH receptor.